Loren Data's SAM Daily™

FBO DAILY ISSUE OF JUNE 13, 2003 FBO #0561
SOLICITATION NOTICE

68 -- Immunohistochemical staining reagents and antibodies

Notice Date

6/11/2003
 

Notice Type

Solicitation Notice
 

Contracting Office

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
 

ZIP Code

20852
 

Solicitation Number

NCI-30071-NG
 

Response Due

6/26/2003
 

Archive Date

7/11/2003
 

Point of Contact

Malinda Holdcraft, Purchasing Agent, Phone (301) 402-4509, Fax (301) 402-4513, - Caren Rasmussen, Lead Contract Specialist, Phone (301) 402-4509, Fax (301) 402-4513,
 

E-Mail Address

holdcram@exchange.nih.gov, cr214i@nih.gov
 

Description

The Specialized Diagnostics Unit of the Laboratory of Pathology, Center for Cancer Research., National Cancer Institute (NCI) plans to procure on a sole source basis with Dako Corporation 6392 Via Real, Carpinteria, CA 93013, immunohistochemical staining reagents and antibodies. The supplies and services herein are commercial as defined in FAR Part 12 and this acquisition is being made in accordance with the test program for using simplified procedure for certain commercial items as authorized in FAR Part 13. The North American Industry Classification System Code is 422210 and the business size standard is 100 employees. The Laboratory of Pathology currently offers tests using numerous reagents and antibodies. Each antibody that is used in the laboratory is subjected to rigorous quality control procedures that test the antibody's reactivity and sensitivity. The reagents are used for diagnostic immunohistochemistry laboratory clinical use as well as for supporting clinical and basic research in the Laboratory of Pathology. The primary Dako reagents and antibodies that are required, include the following: 1) detection reagents, 2) high sensitivity polymer-based amplification systems, 3) high sensitivity non-radioactive amplification systems for immunohistochemical staining, 4) ancillary reagents, 5) antibodies, 6) secondary reagents, 7) negative control reagents, and 8) non-radioactive amplification systems for immunohistochemical staining. As new items are introduced they shall be added to the contract for ordering as needed. Furthermore, the high sensitivity non-radioactive amplification systems for immunohistochemical staining and the high sensitivity polymer-based amplification systems, along with other reagents/antibodies, are proprietary lines that can only be purchased through Dako. Changing vendors at this time would force the laboratory to retest and perform quality control procedures on all of approximately 75 antibodies traditionally ordered from Dako. Even if quality controls are met, the same antibody from other vendors may present differences in staining due to packaging differences (diluent or added carriers). Therefore, to maintain consistency in staining and in the interpretation of the slides, the Laboratory of Pathology must purchase the same antibodies from Dako. There is no other source known by the NCI researcher that can perform the above requirement. Period of Performance: Upon award through twelve (12) months with four (4) with four, one-year options is also anticipated. FAR Clause 52.217-8 Option to Extend Service (11/99) and FAR Clause 52.217-9 Option to Extend the Term of the Contract (3/00) apply. This is not a request for competitive quotation. However, if any interested party believes it can meet the above reagents, antibodies and supplies, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow the NCI researcher to determine if the party can provide the above items. Capability statements must be received in the contracting office by 1 PM (local Washington DC time) on June 26, 2003. If you have any questions, please contact Malinda Holdcraft, Purchasing Agent on (301) 402-4509. A determination by the government not to compete this requirement based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted.
 

Place of Performance

Address: NIH

Zip Code: 20892

Country: USA
 

Record

SN00344498-W 20030613/030611213248 (fbodaily.com)
 

Source

FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |